Search alternatives:
point decrease » point increase (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17021
-
17022
-
17023
-
17024
-
17025
-
17026
-
17027
-
17028
Decreased retrograde flow via lowered blood viscosity affects valve morphogenesis.
Published 2009“…(E–H) Confocal sections of the valve-forming region in (E) control, (F) <i>gata1</i>, (G) <i>gata2</i>, and (H) <i>gata1/2</i> morphants. …”
-
17029
Validation of MAFB to be a direct target of miR-199a-5p in NT2 cells.
Published 2013“…<p>A) Western blot showing expression decreased at protein level of MAFB after miR-199a-5p transfection; B) Luciferase receptor assay demonstrated direct binding between MAFB and miR-199a-5p. 3′-UTR of MAFB containing miR-199a-5p targeting site (MAFB) was cloned to the 3′-end of firefly luciferase (pGL vector). …”
-
17030
Inhibition of <i>miR-10b</i> in HTR8 cells affects expression of targets <i>E-cadherin</i> and <i>KLF4</i>.
Published 2017“…<p>(4A) <i>miR-10b</i> expression levels in HTR8 cells at baseline control conditions, and after transfection with inhibitor. (4B) <i>E-cadherin</i> gene expression by qRT-PCR decreases after inhibition of <i>miR-10b</i> in HTR8 cells, compared to control conditions. (4C) <i>KLF4</i> gene expression by qRT-PCR increases after inhibition of <i>miR-10b</i> in HTR8 cells. …”
-
17031
-
17032
The differences of BOLD signal timecourses (TR = 1.6 seconds) upon perceptual switches in V3A/B, V4v, and hMT+.
Published 2013“…<p>(a) The BOLD signal modulates weakly in V3A/B or V4v. …”
-
17033
-
17034
-
17035
-
17036
-
17037
-
17038
-
17039
What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes
Published 2017“…</p><p>Methods</p><p>The sample consisted of 91 adult outpatients with type 1 or type 2 diabetes and comorbid depressive symptoms (i.e., BDI-II ≥ 14) who were randomized to either individual 8-week CBT (n = 45) or individual 8-week MBCT (n = 46). …”
-
17040
Transporter inhibitor MK571 inhibited the generation and excretion of demethoxycurcumin-<i>O</i>-glucuronides in HeLa1A1 cells.
Published 2019“…<p>(A) MK571 (5 and 20 μM) inhibited the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G1) in extracellular medium; (B) Inhibitory effects of MK571 (5 and 20 μM) on the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G2) in extracellular solution; (C) MK571 (5 and 20 μM) decreased the efflux excretion rates of G1 and G2; (D) MK571 (5 and 20 μM) evaluated the intracellular levels of G1 and G2; (E) MK571 (5 and 20 μM) reduced the overall formation (<i>f</i><sub>met</sub>) of G1 and G2 in HeLa1A1 cell; The concentration of demethoxycurcumin was 4 μM. …”